学会発表一覧
AASLD2018でのPXBマウス・PXB-cells関連研究発表、ブース展示のご案内
2018/11/06
11月9日(金)～13日(火)にMoscone North and South Convention Center (アメリカのサンフランシスコ)で開催されます
The Liver Meeting 2018(AASLD)にて、PXBマウス・PXB-cells関連研究発表、ブース展示があります。
ポスター発表 (会場：Hall C-Poster Hall)
■セッション HBV: New and Approved Therapeies
発表日:11月9日（金） 8:00-17:30(Presentation time:Noon-13:30)
番号：414
演題：Promising Antiviral Combination Therapy Targeting HBV Eradication with Nucleoside Analogue, Interferon, Statin,
and a Novel Compound Derived from Spice
発表者：Dr. Kazuya Okushin (Department of Infection Control and Prevention, The University of Tokyo)
■セッション Hepatitis B:Viology, Pathogenesis, and Immunology
発表日:11月9日（金） 8:00-17:30(Presentation time:Noon-13:30)
番号：528
演題：Regulation of the Hepatitis B Virus Gene Expression and Replication By the Multi-Functional Protein Tardbp
発表者：Dr. Grace Naswa Makokha (Institute of Biomedical & Health Science, Hiroshima University)
番号：529
演題：Liver Fibrosis Induced By Gut Microbes in Chimeric Mice Model with Human Hepatocytes Persistently Infected with
Hepatitis B Virus
発表者：Dr Masaya Sugiyama (Genome Medical Science Project, National Center for Global Health and Medicine)
■セッション Hepatitis C Therapeutics:Approved Agents
発表日:11月9日（金） 8:00-17:30(Presentation time:Noon-13:30)
番号：645
演題：Prevalence of NS5A Resistance Associated Variants in NS5A Inhibitor Treatment Failures and an Effective
Treatment for NS5A-P32 Deleted Hepatitis C Virus in Humanized Mice
発表者：Dr. Yuji Teraoka (Department of Gastroenterology and Metabolism, Applied Life Science, Institute of Biomedical &
Health Science, Hiroshima University)
番号：693
演題：Efficacy of Glecaprevir and Pibrentasvir Treatment for Hepatitis C Virus Drug Resistance-Associated Variants in
Humanized Mice
発表者：Dr. Mitsutaka Osawa (Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science,
Hiroshima University)
■セッション Hepatitis C:Virology, Pathogenesis and Immunology
発表日:11月10日（土） 14:00-19:30(Presentation time:17:30-19:00)
番号：1006
演題：A Novel Jak3KORag2KO Chimeric Mouse Model for the Study of Hepatitis Virus Virology
発表者：Dr. Takuro Uchida (Department of Gastroenterology and Metabolism, Institute of Biomedical & Health Science,
Hiroshima University)
■セッション Liver Fibrogenesis and Non-Parenchymal Cell Biology
発表日:11月10日（土） 14:00-19:30(Presentation time:17:30-19:00)
番号：1121
演題：Screening of Pharmaceuticals for Their Effectiveness in Preventing Liver Fibrosis Using Mice with Humanized Livers,
with an Assessment of the Therapeutic Effect Using Mouse Liver Fibrosis Models
発表者：Dr. Norihiro Sakai (Division of Gastroenterology and Hepatology, Niigata University)
■セッション Pediatric Hapatology
発表日:11月11日（日） 8:00-17:30(Presentation time:12：30-14:00)
番号：1848
演題：Development of Human Ornithine Transcabamylase Deficiency Model Using cDNA-uPA/SCID Chimeric Mice with
Patient Hepatocytes
発表者：Chise Tateno (R&D Department, Phoenixbio Co., Ltd.)
■セッション Clinical and Translational Fibrosis Research
発表日:11月11日（日） 8:00-17:30(Presentation time:12：30-14:00)
番号：2001
演題：The Role of TLL1 in Hepatic Fibrogenesis and Carcinogenesis
発表者：Dr. Kentaro Matsuura (Department of Gastroenterology and Metabolism, Nagoya City University Graduate School
of Medical Sciences)
ブース展示
ブース# 542 (Exhibit Hall)
(会期及び時間)
2018年11月10日(土) 17:00 – 19:30 (Exhibit Hall Opening Reception)
2018年11月11日(日) 9:30 – 15:00
2018年11月12日(月) 9:30 – 15:00
